Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 11:47:11 UTC
Update Date2021-09-26 23:06:32 UTC
HMDB IDHMDB0253369
Secondary Accession NumbersNone
Metabolite Identification
Common NameIcotinib
DescriptionIcotinib belongs to the class of organic compounds known as quinazolinamines. These are heterocyclic aromatic compounds containing a quianazoline moiety substituted by one or more amine groups. Icotinib is a strong basic compound (based on its pKa). Icotinib is approved for use as first-line monotherapy in patients with non-small-cell lung cancer with somatic EGFR mutations. Currently, it is solely approved and marketed in China. The phase IV ISAFE trial evaluated 5,549 patients and showed icotinib to have an overall response rate of 30% and an adverse event rate of 31.5%. The following trial was submitted in January, 2014 and was to begin recruitment in August, 2014. This compound has been identified in human blood as reported by (PMID: 31557052 ). Icotinib is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Icotinib is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
Synonyms
ValueSource
BPI-2009HChEMBL
4-((3-Ethynylphenyl)amino)-6,7-benzo-12-crown-4-quinazolineMeSH
Chemical FormulaC22H21N3O4
Average Molecular Weight391.427
Monoisotopic Molecular Weight391.153206168
IUPAC NameN-(3-ethynylphenyl)-7H,8H,10H,11H,13H,14H-1,4,7,10-tetraoxacyclododeca[2,3-g]quinazolin-4-amine
Traditional NameN-(3-ethynylphenyl)-7H,8H,10H,11H,13H,14H-1,4,7,10-tetraoxacyclododeca[2,3-g]quinazolin-4-amine
CAS Registry NumberNot Available
SMILES
C#CC1=CC=CC(NC2=NC=NC3=CC4=C(OCCOCCOCCO4)C=C23)=C1
InChI Identifier
InChI=1S/C22H21N3O4/c1-2-16-4-3-5-17(12-16)25-22-18-13-20-21(14-19(18)23-15-24-22)29-11-9-27-7-6-26-8-10-28-20/h1,3-5,12-15H,6-11H2,(H,23,24,25)
InChI KeyQQLKULDARVNMAL-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as quinazolinamines. These are heterocyclic aromatic compounds containing a quianazoline moiety substituted by one or more amine groups.
KingdomOrganic compounds
Super ClassOrganoheterocyclic compounds
ClassDiazanaphthalenes
Sub ClassBenzodiazines
Direct ParentQuinazolinamines
Alternative Parents
Substituents
  • Quinazolinamine
  • Aniline or substituted anilines
  • Alkyl aryl ether
  • Aminopyrimidine
  • Monocyclic benzene moiety
  • Pyrimidine
  • Benzenoid
  • Imidolactam
  • Heteroaromatic compound
  • Dialkyl ether
  • Ether
  • Acetylide
  • Secondary amine
  • Oxacycle
  • Azacycle
  • Organonitrogen compound
  • Amine
  • Organooxygen compound
  • Organic oxygen compound
  • Hydrocarbon derivative
  • Organopnictogen compound
  • Organic nitrogen compound
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP2.88ALOGPS
logP3.03ChemAxon
logS-4.5ALOGPS
pKa (Strongest Acidic)16.14ChemAxon
pKa (Strongest Basic)4.62ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count7ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area74.73 ŲChemAxon
Rotatable Bond Count2ChemAxon
Refractivity105.82 m³·mol⁻¹ChemAxon
Polarizability42.08 ųChemAxon
Number of Rings4ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M-2H]-224.56630932474
DeepCCS[M+Na]+199.79330932474
AllCCS[M+H]+193.532859911
AllCCS[M+H-H2O]+190.732859911
AllCCS[M+NH4]+196.132859911
AllCCS[M+Na]+196.832859911
AllCCS[M-H]-192.932859911
AllCCS[M+Na-2H]-192.632859911
AllCCS[M+HCOO]-192.332859911

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
IcotinibC#CC1=CC=CC(NC2=NC=NC3=CC4=C(OCCOCCOCCO4)C=C23)=C14913.1Standard polar33892256
IcotinibC#CC1=CC=CC(NC2=NC=NC3=CC4=C(OCCOCCOCCO4)C=C23)=C13368.7Standard non polar33892256
IcotinibC#CC1=CC=CC(NC2=NC=NC3=CC4=C(OCCOCCOCCO4)C=C23)=C13720.5Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Icotinib,1TMS,isomer #1C#CC1=CC=CC(N(C2=NC=NC3=CC4=C(C=C23)OCCOCCOCCO4)[Si](C)(C)C)=C13495.8Semi standard non polar33892256
Icotinib,1TMS,isomer #1C#CC1=CC=CC(N(C2=NC=NC3=CC4=C(C=C23)OCCOCCOCCO4)[Si](C)(C)C)=C13225.2Standard non polar33892256
Icotinib,1TMS,isomer #1C#CC1=CC=CC(N(C2=NC=NC3=CC4=C(C=C23)OCCOCCOCCO4)[Si](C)(C)C)=C15170.9Standard polar33892256
Icotinib,1TBDMS,isomer #1C#CC1=CC=CC(N(C2=NC=NC3=CC4=C(C=C23)OCCOCCOCCO4)[Si](C)(C)C(C)(C)C)=C13700.0Semi standard non polar33892256
Icotinib,1TBDMS,isomer #1C#CC1=CC=CC(N(C2=NC=NC3=CC4=C(C=C23)OCCOCCOCCO4)[Si](C)(C)C(C)(C)C)=C13429.3Standard non polar33892256
Icotinib,1TBDMS,isomer #1C#CC1=CC=CC(N(C2=NC=NC3=CC4=C(C=C23)OCCOCCOCCO4)[Si](C)(C)C(C)(C)C)=C15224.1Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Icotinib GC-MS (Non-derivatized) - 70eV, Positivesplash10-029i-0296000000-91bcc78f9735119779942021-09-23Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Icotinib GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Icotinib 10V, Negative-QTOFsplash10-0006-0009000000-cd7c412b03e939edc63d2017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Icotinib 20V, Negative-QTOFsplash10-0006-2129000000-df7742984b7ddc5aa6212017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Icotinib 40V, Negative-QTOFsplash10-00g1-6193000000-8b873d67972a297b90832017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Icotinib 10V, Negative-QTOFsplash10-0006-0009000000-473c9abfcfb419a2363d2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Icotinib 20V, Negative-QTOFsplash10-0006-0009000000-bbc706598cfafa661b892021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Icotinib 40V, Negative-QTOFsplash10-01b9-0975000000-72e4247bb4d45c6ecafb2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Icotinib 10V, Positive-QTOFsplash10-000x-1319000000-b7852e0d27d68d1e86252017-07-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Icotinib 20V, Positive-QTOFsplash10-01pp-1029000000-72202e24212d3888431d2017-07-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Icotinib 40V, Positive-QTOFsplash10-01vk-9480000000-ec18f935500546138b7a2017-07-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Icotinib 10V, Positive-QTOFsplash10-0006-0009000000-c406f51f24d1cf16240c2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Icotinib 20V, Positive-QTOFsplash10-0006-0009000000-c406f51f24d1cf16240c2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Icotinib 40V, Positive-QTOFsplash10-01bc-1797000000-dc418a8f79ec3e435ff52021-10-12Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDDB11737
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider IDNot Available
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkIcotinib
METLIN IDNot Available
PubChem Compound22024915
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]